Cargando…
Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study
PURPOSE: Androgen Deprivation Therapy (ADT) is the mainstay treatment in advanced prostate cancer. We conducted a nationwide population-based study to evaluate the association of ADT and cardiovascular diseases. METHODS: Between 2005 and 2009, patient data from the National Health Insurance database...
Autores principales: | Li, Jian-Ri, Wang, Shian-Shiang, Chen, Chuan-Shu, Cheng, Chen-Li, Hung, Sheng-Chun, Lin, Ching-Heng, Chiu, Kun-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239475/ https://www.ncbi.nlm.nih.gov/pubmed/35763533 http://dx.doi.org/10.1371/journal.pone.0270292 |
Ejemplares similares
-
Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study
por: Chen, Wei-Cheng, et al.
Publicado: (2023) -
First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017) -
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
por: Corona, Giovanni, et al.
Publicado: (2021) -
Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel
por: Li, Jian-Ri, et al.
Publicado: (2017) -
Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics
por: Lin, Chia-Yen, et al.
Publicado: (2019)